PARIS Thrombosis Risk Score Calculator

Clinical calculation support · Verify results before clinical use

Thrombotic Risk Assessment

Select the patient's clinical characteristics. The score updates automatically.

0Score
D

Diabetes mellitus

Choose the diabetes category used in the original PARIS thrombotic score.

Up to +3 points

Up to +2 points

Up to +1 points

Up to +2 points

Up to +2 points

Up to +2 points
0PARIS
Thrombotic risk score category
Low score category
Score 0–2: lower score category in commonly used research stratification.
Clinical interpretationUse this score as one component of ischemic-risk assessment after PCI. Review bleeding risk, procedural factors, comorbidities, and the patient's clinical course before making antiplatelet decisions.

The PARIS thrombotic score estimates coronary thrombotic-event risk; it does not independently prescribe DAPT duration or intensity. The score's categories are research stratification bands and do not provide an individualized absolute probability for this patient.

About the PARIS Thrombotic Risk Score

The PARIS (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients) thrombotic risk score was developed to estimate coronary thrombotic events after PCI. In the original score, the endpoint was a composite of stent thrombosis or myocardial infarction, rather than stent thrombosis alone.

This implementation uses the six predictors and point weights reported for the original PARIS coronary-thrombotic-event score. The maximum possible score is 12.

Variables and points

VariableCriterionPoints
Diabetes mellitusNone / non-insulin-dependent / insulin-dependent0 / +1 / +3
Acute coronary syndromeNo ACS / troponin-negative / troponin-positive0 / +1 / +2
Current smokingNo / yes0 / +1
Creatinine clearance≥60 / <60 mL/min0 / +2
Prior PCINo / yes0 / +2
Prior CABGNo / yes0 / +2

Score grouping shown by this calculator

ScoreDisplay category
0–2Lower score category
3–4Intermediate score category
≥5Higher score category

These bands are commonly used in observational applications of the score, but should not be interpreted as universal guideline-defined treatment thresholds.

References

Baber U, Mehran R, Giustino G, et al.Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting Stents: Risk Scores From PARIS. Journal of the American College of Cardiology. 2016;67(19):2224–2234. DOI: 10.1016/j.jacc.2016.02.064. PMID: 27079334.
Zhao X, Li J, Tang X, et al.Prognostic Value of the PARIS Thrombotic Risk Score for 2-Year Mortality After Percutaneous Coronary Intervention. Clinical and Applied Thrombosis/Hemostasis. 2019. PMID: 31215225. This is a secondary application of the score, not the derivation study.
Clinical disclaimer: This calculator is intended for educational and clinical decision support. It does not replace clinician judgment, current guidelines, assessment of bleeding risk, or consideration of patient-specific factors. Do not use the score alone to determine antiplatelet treatment duration.